Published in
American Society of Hematology, Blood, Supplement 1(140), p. 1781-1783, 2022
DOI: 10.1182/blood-2022-157273
Links
Tools
Ruxolitinib Versus Best Available Therapy for PV Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Journal article published in 2022 by
Claire Harrison,
Jyoti Nangalia,
Rebecca H. Boucher,
Aimee Jackson,
Christina Yap 
,
Jennifer O'Sullivan,
Sonia Fox,
Isaak Ailts,
Amylou C. Dueck,
Holly L. Geyer,
Ruben Mesa,
William Dunn,
Eugene Nadezhdin,
Natalia Curto-Garcia,
Anna Green
and other authors.
,
Jennifer O'Sullivan,
Sonia Fox,
Isaak Ailts,
Amylou C. Dueck,
Holly L. Geyer,
Ruben Mesa,
William Dunn,
Eugene Nadezhdin,
Natalia Curto-Garcia,
Anna Green
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 